It’s the best time in a long time to consider the gift that pays you: a charitable gift annuity. Payout rates went up again Jan. 1, 2024, and are higher than they have been in 16 years. Seize the moment by considering this amazing gift that...
Read More
You may contribute to helping speed a cure for Parkinson's disease through a gift in your will or other estate plans. Such gifts are easy to establish and may reduce the estate taxes that may be levied against your property. This charitable...
Read More
The Michael J. Fox Foundation’s Legacy Circle was founded to thank and honor those who have named us in their estate plans. Planned gifts allow you to create a legacy that represents your values and to contribute to a better future for your...
Read More
Patients first
We strive to make progress in Parkinson's disease in the following key areas by evaluating risk, opportunities and challenges through a patient-focused lens, including:
Treatments that can slow, stop or reverse disease
Better treatments for currently unaddressed or under-addressed symptoms
Treatments to address or avoid the debilitating side effects of current PD drugs
Patients first
We strive to make progress in Parkinson's disease in the following key areas by evaluating risk, opportunities and challenges through a patient-focused lens, including:
Treatments that can slow, stop or reverse disease
Better treatments for currently unaddressed or under-addressed symptoms
Treatments to address or avoid the debilitating side effects of current PD drugs
Our model is different
Our Foundation is a trusted strategic leader and partner to researchers, patients, thought leaders and philanthropists. With an unbiased expert perspective and a global network of contacts, our wide-ranging view of the field lets us collaborate to solve complex problems that require different talents and target resources where they are needed most — to pay off for patients faster.
It is accepted practice among private disease research funders that the most important decisions — how to allocate donor-raised dollars — are made by external scientific advisors and boards. We bucked this model from day one in favor of building an in-house team of formally trained PhDs and business-trained project managers.
We’re on a mission to meet every person with Parkinson’s online or face to face. We're committed to connecting patients and families to the robust nationwide PD community. By participating in clinical trials, advocating for Parkinson's policy or engaging in our community and Team Fox events, they are helping us carry new therapies over the goal line.
Our model is different
Our Foundation is a trusted strategic leader and partner to researchers, patients, thought leaders and philanthropists. With an unbiased expert perspective and a global network of contacts, our wide-ranging view of the field lets us collaborate to solve complex problems that require different talents and target resources where they are needed most — to pay off for patients faster.
It is accepted practice among private disease research funders that the most important decisions — how to allocate donor-raised dollars — are made by external scientific advisors and boards. We bucked this model from day one in favor of building an in-house team of formally trained PhDs and business-trained project managers.
We’re on a mission to meet every person with Parkinson’s online or face to face. We're committed to connecting patients and families to the robust nationwide PD community. By participating in clinical trials, advocating for Parkinson's policy or engaging in our community and Team Fox events, they are helping us carry new therapies over the goal line.